(Q41465895)

1 October 2017

1 reference

title

Weight gain in women diagnosed with breast cancer (English)

1 reference

1 October 2017

1 reference

Demark-Wahnefried W

1

1 reference

1 October 2017

Rimer BK

series ordinal

2

1 reference

1 October 2017

Winer EP

series ordinal

3

1 reference

1 October 2017

language of work or name

1 reference

1 May 1997

1 reference

Journal of the American Dietetic Association

1 October 2017

published in

1 reference

1 October 2017

volume

97

1 reference

1 October 2017

issue

5

1 reference

1 October 2017

page(s)

519-26, 529; quiz 527-8

1 reference

1 October 2017

cites work

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Megestrol acetate: phase II study of a single daily administration in advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. The Women's Intervention Nutrition Study (WINS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

The association of body weight with recurrent cancer of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Why women gain weight with adjuvant chemotherapy for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Weight gain in women with localized breast cancer--a descriptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Weight gain during adjuvant chemotherapy for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Weight gain with breast cancer adjuvant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Weight gain after primary surgery for breast cancer--effect of tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Rehabilitation needs and breast cancer: the first month after primary therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Nutritional concerns of women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Body size and breast cancer prognosis: a critical review of the evidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Biological characteristics of breast cancer in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Height, weight, and risk of breast cancer relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Estrogen receptors and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Cholesterol and obesity as prognostic factors in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Relationship of weight to the promotion of breast cancer after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

The effect of pre-morbid height and weight on the survival of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Obesity and breast disease. The role of the female sex hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Obesity, body fat distribution, and sex hormones in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Dietary lipids and immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Eating fat or being fat and risk of cardiovascular disease and cancer among women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Can a tumour cause the same appetite perversion or taste change as a pregnancy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Adjuvant chemotherapy for breast carcinoma:Psychosocial implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Validation and comparison of eight physical activity questionnaires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Resting energy expenditure in controls and cancer patients with localized and diffuse disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Energy expenditure in malnourished cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Unpublished Data Summaries and the design and conduct of clinical trials. The Nutrition Adjuvant Study experience and commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Weight loss in women participating in a randomized trial of low-fat diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2897%2900133-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8223(97)00133-8

1 reference

1 October 2017

1 reference